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Nanomedicine is the engineering application of 
nanotechnology to medicine. It is the engineering of 
molecularly precise structures typically 0.1 mm or 
smaller and ultimately, molecular machines. It is the 
preservation and improvement of human health, using 
molecular tools and molecular knowledge of the human 
body.1Nanomedicine this generation exploits various 
nanoparticle devices such as dendrimers, carbon 
fullerenes (buckyballs) and nanoshells to target specific 
tissues and organs. These nanoparticles may serve as 
diagnostic and therapeutic antiviral, antitumor or 
anticancer agents. Nanomedicine uses organic polymer 
or lipid-based systems such as polymeric micelles, 
liposomes and solid lipid nanoparticles, and various 
nanocrystal based systems which are now leading 
nanodevice market products. Drug delivery and related 
pharmaceutical development in the context of 
nanomedicine consists of at least two components, one of 
which is a pharmaceutically active ingredient, although 
nanoparticle formulations of the drug itself are also 
possible. The whole system leads to a special function 
related to treating, preventing or diagnosing diseases 
sometimes called smart-drugs. In the medical world, 
nanotechnology is also seen as a boon since these can 
help with creating smart drugs. These help to cure people 
faster and without the side effects that other traditional 
drugs have. We will also find that the research of 
nanotechnology in medicine is now focusing on areas 
like tissue regeneration, bone repair, immunity and even 
cures for such ailments like cancer, diabetes, and other 
life threatening diseases. The primary goals for research 
of nano-bio-technologies in drug delivery include:2 
 More specific drug targeting and delivery, 
 Reduction in toxicity while maintaining therapeutic 
effects, 
 Greater safety and biocompatibility, and 
 Faster development of new safe medicines. 
Nanomedicine: 
Nanomedicine refers to highly specific medical 
intervention at the molecular scale used for curing 
disease or repairing damaged tissues such as bone, 
muscle, or nerve.  Nanometer is defined as one-billionth 
of a meter. Biological molecules and structures inside 
living cells operate at the size scale of about 100 
nanometers or less.3 Nanomedicine, enabled the 
development of nanoparticle therapeutic carriers which 
as systems are selectively and passively target to tumors 
through the enhanced permeability and retention effect, 
so they are perfectly ready for the deliverance. 
 
ABSTRACT 
Nanobiopharmaceuticals has involved, understanding issues related to target specific drug delivery. Previously the traditional 
dosage forms showed a greater difficulty in achieving bioavailability and therapeutic index. So addition of various 
functionalities to nano size materials interfacing them into various biological molecules has improved the drug delivery. 
Integration of nanomedicinals with biotechnology has brought a radical change in the research field both in vivo and invitro.  It 
has paved the way to new therapies, surgical interventions and advanced drug delivery systems. Nanoparticles as 
nanomedicines opens the potential for crossing various biological barriers within the body especially the potential to cross the 
blood brain barrier may open new ways for drug delivery into the brain. Nanoparticles as drug delivery systems can be 
designed to improve the pharmacological and therapeutic properties of the drug. This manuscript has emphasized various 
nanobiopharmaceuticals in the field of cancer therapy, regenerative medicine, drug delivery, diagnostic devices, gene therapy 
and tissue engineering. 
Keywords:  Nanobiopharmaceuticals, target specific drug delivery, regenerative medicines, tissue engineering, cancer therapy. 
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Figure 1: Typical size of nano- and micro-objects (horizontal axis: log-scale) from left- to right: (a) Hydrogen atom 
(~0.1nm) , (b) water molecule (diameter: ~0.4nm), (c) peptide aptamer (size ~3nm), (d) lipid bilayer (thickness ~5nm), 
(e) protein (size ~10nm), (f) antibody (size ~10nm), (g) ribosome (diameter ~30nm), (h) human papillomavirus 
(diameter ~60nm), (i) mitochondrion (length ~1 um), (j) Helicobacter pylori (length ~3um), (k) nucleus (diameter 
~3um), (l) erythrocyte (diameter ~8um), (m) mammalian cell (diameter ~20um).4 
  
Mechanism of drug delivery via nanoparticle: 
Nanoparticles help in providing site specific drug 
delivery by enhancing permeability and retention effect 
without passing into the reticuloendothelial system. 
There are two main methods which are generally used or 
applied with drug using nanoparticle as carrier for 
enhanced permeability and retention effect. 
1) Surface bound method: In this method, the drug 
particles are adhered to the surface of the   nanoparticles. 
2) Core bound method: In such methodology, the drug 
particles are concentrated to the matrix of the 
nanoparticle and are carried to the targeted site into the 
body. 
Drugs are delivered by the help of nanoparticles by 
adding them to a reaction mixture during polymerization 
process. The main aim of delivering drugs via 
nanoparticle is not only to provide better therapeutic 
results but also to reduce cost and tumor suffering by 
reducing the cost of drugs to the public health 
system.5The potential of eliminating a tumorous 
outgrowth without any collateral damage through 
nanomaterial based drug delivery have laid to design 
drug delivery systems on functionalized nanoparticles. 
Nanoparticles were earlier used as a carrier for vaccine 
and anticancer drugs. The successful result of 
nanotechnology in the field of nanomedical sciences is 
the delivery of drugs through the blood brain barrier for 
targeting brain tumors. Doxorubicin is an anticancer drug 
but it cannot cross the blood brain barrier. Thus 
integration of Doxorubicin with polysorbate 80 leading 
to the formation of polybutylcyanoacrylate nanoparticles 
can increase its delivery to the brain to a large extent. 
Nanoparticles have the ability to penetrate deep into 
tissues and get absorbed by the cells efficiently. They 
play a vital role in the creation of DNA delivery vectors. 
Submicron colloidal particles have been used as 
nanoparticles for the purpose of drug delivery and they 
act as major carriers for several classes of drugs like 
anticancer, antihypertensive and hormones.6 
The procedure generally involved for targeted drug 
delivery by the help of nanoparticle include:- 
Step1 
The drug of interest is dissolved, entrapped, adsorbed, 
attached or encapsulated into or onto a matrix. 
Step2 
Thus depending on the method of preparation 
Nanoparticles, nanospheres or nanocapsules can be 
constructed to possess different properties and release 
characteristics for the best delivery or encapsulation of 
therapeutic agents. 
Deliveries of drug by the help of nanoparticle have the 
following advantages: 
  1) High surface to volume ratios 
2) Modifiable platforms 
3) Tunable size 
The size and shape of nanoparticle is highly important 
for application in drug delivery processes as they control 
the perfusion of materials through the endothelium and 
diffusion through tissues.7 
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Figure 2: Example of metal nanoparticles, dendrimers, peptide-based nanoparticles, liposomes, carbon nanotubes and 
quantum dots that help in drug delivery system6 
Nanotechnology in cancer treatment: 
Cancer is the most dreadful disease of the century. Many 
drugs are being researched everyday for treating this 
dreadful disease. Cancer is also known as malignant 
neoplasia. In cancer, cells divides and grow uncontrollably 
leading to the formation of a primary tumor mass followed 
by vascularisation and then finally subsequent spread of 
cancer cells to other parts of the body where secondary 
tumor formation takes place. They may travel to various 
parts of the body through lymphatic system or blood 
streams. Today cancers are of many types mainly lungs, 
stomach, liver, blood, colon and breast cancer. Exposure to 
radiations, lack of physical activity, obesity and effects of 
carcinogens such as tobacco, smoke, chemicals and 
infectious agents causes cancer. The two general classes of 
genes that are affected by the unrestricted growth of cell 
leading to genetic abnormalities are 
1. Proto-oncogenes 
2. Tumor suppressor genes 
Proto-oncogenes stimulates cell division and their mutated 
forms are called as oncogenes, in the contrast Tumor 
suppressor genes, codes for proteins that inhibit cell division 
whose adverse effects include loss of normal DNA 
replication, control over the cell, orientation and adhesion 
with tissues and interaction with the protective cell of the 
immune system. The present trend of treatment options for 
cancer includes surgical resection, radiation and 
chemotherapy. Dose limiting toxicity and patient morbidity 
are the speed breakers that affect the efficacy of 
chemotherapeutic drugs. At these stage nanomedicines, an 
advancement of nanotechnological science has emerged as 
novel therapeutic modalities for cancer treatment. 8 
 
Figure 3: Advantages of drug encapsulated in a nanopoarticle over free drug9 
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Monitorpost-treatment relapse technique:-This is another 
nanoscale device that is used for the treatment of 
cancer.Nanoscale sensor is planted into the body and is 
capable of detecting the growth of cancerous cells in 
patients. This technique is very helpful in detecting cancer 
cells at an early stage which would reduce mortality rates 
dramatically.10 
Nanoparticles generate supersonic shock waves to target 
charge:- A nanosized bomb is used for target drug delivery 
to cancer tumors without damage to any other cells. The 
nanothermites produce shock waves in the Mach3 range. 
The drugs are administered via needle by the help of a 
device which would send a pulse into the tumor. 
Nanoscale therapeutic systems include polymeric micelles, 
polymers-drug-conjugates, dendrimers and inorganic 
particulates and these play a vital role in treatment of cancer. 
Liposome Nanoparticles for cancer:- 
Lipids help in the formation of nanoparticle vesicles through 
the self assembly of amphiphillic liquids and excipients.The 
liposomal formulation is a bilayer based on hydrophobic 
interactions with the hydrophilic head groups positioned 
towards the aqueous environment. The physical and 
chemical properties of liposomes can be precisely changed 
to control surface change, size and functionality.These can 
be achieved by simple mixing commercially available lipid 
molecules. 
A pegylated liposome DOXIL which is used to treat multiple 
types of cancer is a better example to understand liposome 
liposomal drug delivery systems. Doxin is loaded with 
doxorubicin by diffusion process based on an ammonium 
salt gradient. The nanocarriers containing the drug or 
therapeutic load is released into the cytoplasm by changing 
the zeta potential with changes in solution pH.9 
Polymer drug conjugate nanoparticles for cancer:- 
The side chain grafting of drugs to polymer chains helps in 
the delivery of high doses of chemotherapeutic drugs and 
thus leads to the formation of polymer drug conjugates. The 
size of polymer drug conjugates is generally below 
20nm.HPMA-doxorobucin, Xyotax are some of the nano 
drugs that are presently under trials for multiple cancer 
therapeutics including prostate, breast, neck, colorectal 
cancer and recurrent NSCL. Xyotax is commonly called as 
polyglutamate paclitaxel, Paclitaxel is grafted to 
polyglutamic acid to reach a drug load of 80-40% by 
weight.9 
Biological nanoparticles for cancer:- 
Bacteria are biological nanoparticles that are unicellular 
microorganism which encapsulate essential components of 
the cytoplasm as well as hydrophobic and hydrophilic 
molecules."Nanocell" is an example of biological 
nanoparticles which is being used for cancer therapy which 
mainly consists of anucleate globular bacteria having size 
nearly about 400nm.It has no signs of toxicity when 
experimented with large animals such as pigs and monkeys 
with repeated dosages at high titers. The main advantage of 
Nanocells is that it can be loaded with molecules of different 
solubility and charge such as doxorobucin, paclitaxel 
through drug diffusion into bacteria within a few hours.9 
The novel prospects in nanomedicine for enhanced tumor 
treatment include 
1. Active Targeting Strategies 
2. Controlled Release strategies 
3. Multistage drug Delivery 
Nanotechnology for CNS drug delivery: 
The part of the nervous system consisting of the brain and 
spinal cord is called Central nervous system. The brain is a 
challenging organ for drug delivery. First, the incidence of 
degenerative diseases in the brain will increase with the 
aging population. Secondly, the blood brain barrier 
(BBB) is well-known as the best gatekeeper in the body 
toward exogenous substances .All the current therapeutic 
strategies are not efficient in treating disorders related to the 
CNS.The disease alleration symptoms are partial as opposed 
to disease modifying effects. With increasing rise in 
demographics, there is also dramatically increase in 
neurodegenerative disease. The current therapeutic treatment 
procedures are associated with severe side effects.CNS 
disorders are one of the essential and largest areas in 
pharmaceutical world and hence require adequate treatment. 
Thus biotherapeutic agents like proteins, peptides, 
monoclonal antibodies, growth factors and nucleic acids are 
performed under trials to have a profound effect on halting 
the progression of neurodegenerative disorders and also 
helps in providing unique function of restoring damaged 
cells.11Drug delivery to the cns for therapeutic advancement 
of nanodegenerative disorders such as Alzheimer‟s is 
complicated by restrictive mechanism imposed at the blood 
brain barrier. Hence opsonisation by plasmaprotiens in the 
systemic circulation is additional impedance to cerebral drug 
delivery for treatment of Alzheimer‟s disease.12 
Major barriers to CNS delivery include:11 
1. The blood-brain barrier (BBB): The selective permeability 
barrier that separates the circulating blood from the brain 
extracellular fluid in CNS is the blood brain barrier. It 
maintains the constancy of the internal environment of the 
brain. It protects the brain from foreign substances in the 
blood that may injure the brain. It also protects the brain 
from hormones and neurotransmitters. In the blood brain 
barrier, macromolecules are unable to cross the capillary 
brain endothelial cells as they form tight junctions preventing 
most of the potential drugs from reaching their CNS targets. 
The table1. Drawn below shows different transport pathways 
across blood brain barrier. Transcellular lipophillic pathway 
and adsorptive transcytosis are prominent transport pathways 
in drug delivery across the BBB. Most drugs enter the brain 
via transcellular lipophillic pathway.     
2. The blood-cerebrospinal fluid barrier: The choroid plexus 
epithelial cells and the arachnoid membrane form the blood 
cerebrospinal fluid barrier. Ependymal epithelium is the 
functional unit of choroid plexus. It has less surface area and 
hence pose les obstacle in drug delivery to CNS. The BBB 
possesses tight junctions between the endothelial cells 
whereas the blood-CSF barrier posses tight junctions 
between the epithelial cells of the choroid plexus thus 
preventing the drug from entering the CSF. 
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Table 1: Different transport pathways across blood brain barrier 11 
Name of the transport 
pathway 
     Agents involved                     Description 
Paracellular aqueous 
pathway 
Water soluble agents Tight junctions present in blood brain restrict penetration 
of water soluble agents. 
Transcellular 
lipophillic pathway 
Lipid-soluble agents Lipid bilayer membrane of the endothelium provides 
diffusive route for lipid-soluble agents 
Transport proteins Glucose,aminoacids,nucleoside,vi
nca alkaloids,cyclosporinA,AZT 
The endothelium contains transport carriers for 
glucose,aminoacids and other substances 
Receptor Mediated 
Transcytosis 
Insulin,Transferin Protein such as insulin and transferrin are taken up by 
specific receptor mediated endocytosis and transcytosis. 
Adsorptive 
Transcytosis 
Albumin, other plasma proteins It uptakes native plasma proteins such as albumin. 
 
Nanosuspensions and Liposomal Nanomedicines: 
Nanosuspension:10 13 14 15 
Nanosuspension is a biphasic system consisting of pure 
drug particles dispersed in an aqueous vehicle in which 
the diameter of the suspended particle is less than 1μm in 
size and stabilized by surfactants. Nanosuspensions can 
be used to enhance the solubility of drugs that are poorly 
soluble in aqueous as well as lipid media. As a result, the 
rate of flooding of the active compound increases and the 
maximum plasma level is reached faster. More than 40 
percent of the drugs are poorly soluble in water. 
Obviously poorly water soluble drugs show many 
problems in formulating them in conventional dosage 
forms. Critical problems associated with poorly soluble 
drugs are:   
1. Low bioavailability 
2. Erratic absorption. 
Drugs having such properties are Itraconazole and 
Carbamazepine. Nanosuspensions formulation approach 
is used for drugs with high log P value, high melting 
point and high dose. The major advantages of 
nanosuspensions are 
1. Increase in the dissolution velocity and saturation 
solubility of the drug. 
2. Improved biological performance. 
3. Ease of manufacture and scale-up. 
4. Long-term physical stability. 
5. Versatility. 
Table 2: Potential benefits of Nanosuspension 
technology over other Conventional formulation 
technologies over poorly soluble drug15 
Drug Formulations Benefits of Nanosuspensions 
Oral *Rapid onset 
*Improved bioavailability 
Intravenous *Rapid Dissolution 
*Tissue Targeting 
Ocular *Higher bioavailability 
*More consistent dosing 
Inhalation *Higher bioavailability 




*Reduced tissue irritation 
 
 
Application of nanosuspensions in drug delivery: 
1. Oral drug delivery: 
Antibiotic indicated for non-complicated P. falciparum 
malaria and leishmanial infections shows poor 
bioavailability (10–15%) because of its dissolution-rate 
and limited absorption and has to be administered in high 
doses (750 mg twice daily).Administration of 
atovaquone as a nanosuspension resulted in a 2.5-fold 
increase in oral bioavailability as compared to the 
commercial product. 
2. Parenteral drug delivery: 
Clofazimine, a poorly water-soluble anti-leprotic drug, 
has been successfully formulated as a nanosuspension. 
Absence of any harsh solvents/co-solvents and/or any 
potentially toxic ingredient in nanosuspensions enables 
them to bypass the limitations of parentral administration 
attributed to conventional formulations strategies. Hence, 
nanosuspensions enable significant improvement in the 
parentrally tolerable dose of the drug, leading to a 
reduction in the cost of the therapy and also improved 
therapeutic performance. 
3. Ocular drug delivery: 
Nanosuspensions can prove to be a boon for drugs that 
exhibit poor solubility in lachrymal fluids. For delivery 
of such drugs, approaches such as suspensions and 
ointments have been recommended. Although 
suspensions offer advantages such as prolonged 
residence time in and avoidance of the high tonicity 
created by water-soluble drugs. 
4. Pulmonary drug delivery: 
  Budesonide, a poorly water-soluble corticosteroid, has 
been successfully formulated as a nanosuspension for 
pulmonary delivery. Currently such drugs are delivered 
as suspension aerosols or as dry powders by means of 
dry powder inhalers. 
5. Targeted drug delivery: 
Nanoparticulate systems have shown tremendous 
potential in targeted drug delivery, especially to the 
brain. Successful targeting of the peptide dalargin to the 
brain by employing surface modified polyisobutyl 
cyanoacrylate nanoparticles has been a major 
achievement in targeted delivery. 
Panda et al              JDDT; Special Issue1: "Drug Delivery using Nanomedicine & Nanotechnology"              103 
© 2011-14, JDDT. All Rights Reserved                                      ISSN: 2250-1177                                    CODEN (USA): JDDTAO 
Liposomes and biopolymer fields have led to recent 
advancements in the field of nanomedicines with the 
help of carrier systems that are capable of encapsulating 
therapeutic agents which ranges from conventional drugs 
to the new genetic drugs like antisense oligonucleotides 
or small interfering RNA(siRNA). Liposomes have 
advantages over polymer based nanoparticles for 
formation of therapeutics. The main motive in 
developing a liposomal nanomedicine is to design  a 
liposomal nanoparticle allowing the drug particle to 
accumulate at the site of interest associated with either an 
appropriate rate of drug retention or the ability to taken 
up by target cell. Liposomes represent a highly flexible 
platform. The range from multi laminar vesicles with 
diameters of several microns to small, unilaminar 
vesicles with the diameter of 20 nm. 




Genetic drugs help in generating gene expressions and 
presents DNA vectors for ribozymes, gene therapy and 
antisense oligonucleotides. Antisense oligonucleotides 
possess immunostimulatory applications. Genetic drugs 
exhibit inherent sensitivity to rapid inactivation by 
nucleases and rapid elimination from circulation for the 
formulation of liposomal nanoparticles. The 
nanoparticles should be of well defined sizes for 
effective biodistribution and perfect accumulation at 
disease sites. 
Nanomedical Devices: 
1. Nanobiosensor: A device that responds to 
chemical species in biological samples or using 
biological components is called as biosensor. It 
integrates a biological element with a physiochemical 
transducer. The transducer produces an electronic signal 
proportional to a single analyte. The major component of 
biosensor include:17 
1) Biological element           5) nucleic acid        9) 
receptor 
2) Microorganism                6) organelle            10) 
antibody 
3) Tissue                                7) enzyme 
4) Cell                                    8) enzyme component      
All these components help in binding the targeted 
molecule. The physiochemical transducer measures the 
physical change by acting as an interface occurring 
during the reaction at the bioreceptor and then 
transforming that energy into measurable electrical 
output. The transducer passes signals to a microprocessor 
where they are amplified and analyzed. The potential 
applications of nanobiosensor include: 
1) Clinical diagnostics 
2) Food and agricultural processes 
3) Detection of warfare agents 
Nanobiosensors are effectively used for sensing a wide 
variety of fertilizers, pesticides, herbicide, pathogens, 
and moisture and soil pH.  The various types of 
biosensor include:18 
1) Optical biosensors 
2) Nanotube based biosensor 
3) Electrical biosensor 
4) Viral nanosensors 
5) Electrochemical biosensors 
6) Nanoshell biosensors 
7) Nanowire biosensors 
Medical application of nanobiosensor includes:19 35 
1)Identification of particular cells or places in the body 
in need by measuring changes in 
volume,concentration,displacement,velocity,gravitational
,electrical and magnetic forces. 
2) It helps in recognizing tumor cells, most notably those 
off cancer, at the molecular level in order to deliver 
medicines. 
2. Nanorobots: Medical nanorobots helps in performing 
in vivo cytosurgery.An in vivo cytosurgery known as 
chromosome replacement therapy, a nanorobot extracts 
existing chromosomes from a particular diseased cell and 
replaces them with new ones in the same cell. Synthetic 
microbes called biobots which are engineered bacterial 
microbes that helps in the production of useful vitamins, 
hormones, enzymes and cytokines to nourish the 
deficiency in the patient body.5Vascular system helps in 
the introduction of surgical nanorobots into the body. 
Another engineered nanorobot is “FEMTOLASER” 
which is used for performing anatomy of roundworm 
neurons after which the axons functionally regenerate. A 
femtolaser acts like a pair of “nano-scissors” by 
vaporizing tissue locally while leaving the adjacent 
tissues unharmed. Femtolaser surgery has performed the 
following operations successively which includes: 
1) Localized nanosurgical ablation of focal adhersions 
adjoining living mammalian epithelial cells. 
2) Microtube dissection inside yeast cells 
3) Non invasive intratissue nanodissection of plant cell 
walls and selective destruction of intracellular single 
plastids. 
Another most advancing feature of nanorobts in 
nanomedicine is “microbives” that could patrol the blood 
stream, seeking out and digesting unwanted pathogens 
including bacteria, viruses or fungi.It helps in complete 
clearance of severe septicemic infection in hrs or less. 
Nanorobots do not increase the risk of septics because 
the pathogens are completely converted into harmless 
sugars, amino acids.20 
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Figure 4: Nanorobotic artificial phagocytes called 
„„microbivores‟‟that could patrol the bloodstream, 
seeking out and digesting unwanted pathogens.20 
 
3.Nanopores: Fabrication of tiny cell containing 
chambers within single crystalline silicon wafers can be 
achieved by the help of nanopores.These chambers 
interface with the biological environment present in the 
surrounding through polycrystalline silicon filter 
membranes having high density and nanopores of 
uniform size of 20nm allowing passage of small 
molecules such as oxygen, glucose and insulin but 
restrict the passage of large immune system molecules 
such as immunoglobulin and graft borne-virus 
particles.19Nanopore materials are used in the treatment 
of several chronic medical conditions including diabetes 
mellitus. Nanopores can be used as devices to protect 
transplanted tissues from the host immune system 
utilizing the benefit of transplantation. Beta cells of 
pancreas can be enclosed within the nanopore device and 
implanted in the recipients body. This provides the tissue 
sample nutrients from the surrounding tissues and at the 
same time remain undetected by the immune system. 
This hence serves as a new modality for treatment for 
insulin dependent diabetes mellitus. Nanopores play 
major role in DNA sequencing. Recent researches are 
being made on modified nanopores that have the ability 
to differentiate DNA strands based on difference in base 
pair sequence. Researches are also being done on 
nanopores that have the ability to differentiate purines 
from pyridines.21 On a recent research inorganic 
nanoporous materials with well ordered phases such as 
imodic alumina and nanoporous silica have gained 
considerable attention for use in biomedical 
application.22 
4. Quantum dots: Quantum dots are those nanomedical 
devices having tiny crystal particles that grow when 
stimulated by ultraviolet radiation. They are mainly used 
to detect cancer and identify their location in the body. 
They bind to the sequence of DNA that is associated 
with disease. They work on a specific mechanism that is 
the quantum dots get stimulated with light and hence 
emit unique bar codes making the cancer associated 
DNA visible. These structures offer new capabilities for 
multicolor optical coding in gene expression studies, 
high throughput screening, and in vivo imaging.23 
5. Dendrimer: A dendrimer is a molecule having the 
potential to link treatment with detection and diagnosis. 
They have the size as that of an average protein molecule 
and are branched. Thus their surface area increases 
allowing scientists to attach therapeutic agents or 
biologically active molecule. Dendrimers are used to 
distribute genes to cells without triggering a negative 
immune retort.24  They are mainly used in the treatment 
of cancer. The major components of a dendrimer 
includes:- 
1) A molecule that recognizes a cancer cell 
2) A therapeutic agent to kill those cells 
3) A molecule that recognizes the signals of cell 
death 
6. Nanotubes: Advancement in the field of 
nanotechnology has led to the discovery of a growing 
number of new materials including the “CARBON 
NANOTUBES”. Nanotubes are generally carbon rods 
which are about half the diameter of a molecule of DNA. 
They help to identify DNA changes associated with 
cancer. Nanotubes have the ability to detect the presence 
of altered genes and can find the exact location of their 
changes. They can also detect the specific mutations in 
the DNA and hence bind to them. They are also used for 
providing structure for broken bones allowing new bone 
material to grow.25 34 
 
Fig 5: A nanotube crosses a biological barrier to deliver 
drugs, antibodies, diagnostic devices, or possibly all 
three.26 
7. Nanopore sequencing: This is an ultra-rapid method 
of sequencing based on pore nanoengineering and 
assembly. A small electric potential draws a charged 
strand of DNA through a pore of 1–2 nm in diameter in a 
haemolysin protein complex, which is inserted into a 
lipid bilayer separating two conductive compartments. 
The current and time profile is recorded and these are 
translated into electronic signatures to identify each base. 
This method can sequence more than 1000 bases per 
second. This technology has much potential for the 
detection of single nucleotide polymorphisms, and for 
gene diagnosis of pathogens. 27 
8. Super paramagnetic iron oxide crystals: These 
entities are usually prepared by the alkaline co-
precipitation of appropriate ratios of Fe2+ and Fe3+ salts 
in water in the presence of a suitable hydrophilic 
polymer such as dextran or poly(ethylene glycol). This 
yields an iron core of 4 –5 nm in diameter, which is 
hexagonally shaped and surrounded by dextran or 
poly(ethylene glycol) molecules. These crystals possess 
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large magnetic moments when brought into a magnetic 
field, thus producing a localized disturbance in magnetic 
field homogeneity, but the magnetic memory is lost 
when the field is removed. Due to such induced magnetic 
disturbances, there exist a large susceptibility difference 
between super paramagnetic iron oxide crystals and the 
nearby protons, causing rapid dephasing of spins and 
resultant decrease in T2 relaxation times with a loss of 
local signal intensity. But the effects of these crystals on 
T1 relaxation times are relatively minor, compared with 
the T2 effects. These crystals are therefore “negative 
enhancers”. 
Iron oxide crystals are also amenable to surface 
functionalization with small surface functional groups or 
multivalent small molecules as well as by conjugating 
proteins, antibodies, and oligonucleotides for active-
targeting in vivo or for in vitro diagnostic procedures. 
Recently a number of small libraries of surface-
functionalized iron oxide nanoparticles were synthesized 
from the parent aminated dextran caged iron oxide 
nanoparticles. These parent particles were first labeled 
with fluoresceins, thus generating particles that are both 
magnetic and fluorescent, then activated with N-
succinimidyl 3-(2-pyridyldithio) propionate, and reacted 
with thiol-containing surface modifiers. Fluorochrome 
attachment allows the screening by a wide range of high-
throughput fluorescence-based screening methods as 
well as FACS.28 29 30 
Nanotechnology in Tissue engineering: 
Human tissue engineering and regenerative medicine in 
general brings out excellent results in improving patient 
treatment, faster recovery, improved prognosis and a 
proper biologically favorable situation where the body 
can be stimulated to heal itself. According to 
EDUCOME (European Medical Technology Industry 
Association) Regenerative medicine/tissue engineering is 
a rapidly growing multidisciplinary field involving the 
life, physical and engineering sciences that seeks to 
develop functional cell, tissue, and organ substitutes to 
repair, replace or enhance biological function that has 
been lost due to congenital abnormalities, injury, disease, 
or ageing.31Number of researches carried out in the field 
of nanotechnology has led to the creation of implantable 
tissues, some of which are already used in humans like 
skin and cartilage and have also entered clinical trials 
like bladder and blood vessels. Cells seeded into three 
dimensional biocompatible scaffolds under suitable 
bioreactor conditions results into functional structures 
resembling native tissues. To recapitulate proper tissue 
functionality, scaffolds should also establish a tissue 
specific microenvironment to maintain and regulate all 
behavior and function. The development of scaffolds 
which mimic the architecture of tissue at the nanoscale 
level is one of the major challenges in the field of tissue 
engineering. To meet this challenge the development of 
“nanofibres” has enhanced the scope of nanomedicine in 
tissue engineering. Electro spinning, self assembly and 
phase separation are the three techniques which are 
currently available for the synthesis of nanofibres. 
Nanofibres acts as an efficient carrier for the controlled 
delivery of protein, drugs and DNA.33 The hierarchically 
arranged nanofibres within the extracellular matrix 
provides cell support and plays a vital role in storing, 
releasing and activating a wide range of biological 
factors thus providing successful regeneration of tissues. 
Nanotopographic surfaces and nanofeatured scaffolds are 
the recent advancement in the field of nanotissue 
engineering as they encapsulate and control the 
spatiotemporal release of drugs.32 
CONCLUSION: 
Nanomedicine plays an important role in health systems 
by focusing on patient treatment with efficient case 
management but also on development of innovative 
health policies. On a recent research, to control the 
administration of insulin doses, nanopumps are generally 
used. They control the delivery at nanolitre level which 
is very close to physiological delivery of insulin. 
Nanomedicine also helps in reducing the amount of 
precious reagents required to carry out screening of 
potential drugs. They help in the identification of 
targeted protein and drugs. The main objective for 
nanomedicine is to develop cure for diseases like cancer 
through the utilization of nanotechnology and with fewer 
side effects by means of targeted drug delivery systems. 
Nanotechnology will bring out revolutionary changes in 
the field of medical sciences over the coming next 10-20 
yrs.Nanomedicine lags behind because of lack of 
financial profit, consumer distrust and ineffective 
regulation of new and genetic products. But overall 
nanomedicine as a part of nanotechnology is a boon to 
the present and future generation of mankind. 
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